Regeneron Pharma bags USFDA nod for Evkeeza for young children with ultra-rare form of cholesterol Ruchika Sharma23 March 2023 10:00 AM ISTHomozygous familial hypercholesterolemia occurs when two copies of the FH-causing genes are inherited, one from each parent, resulting in dangerously...
Regeneron Pharma Evkeeza under USFDA priority review for children with Ultra-rare inherited form of high cholesterol Ruchika Sharma4 Dec 2022 2:15 PM ISTTarrytown: Regeneron Pharmaceuticals, Inc. has announced the U.S. Food and Drug Administration (USFDA) has accepted for Priority Review the...
FDA approves alirocumab for homozygous FH as addon therapy Dr. Kamal Kant Kohli2 April 2021 6:50 AM ISTThe US food and drug administration (FDA) has expanded approval of Praluent (alirocumab) injection for adult patients with homozygous familial...
PCSK9 inhibitor Evinacumab may significantly lower LDL cholesterol in FH: NEJM Medha Baranwal21 Aug 2020 11:30 AM ISTDelhi: Evinacumab significantly lowers LDL cholesterol levels in patients with homozygous familial hypercholesterolemia receiving maximum...
10 year old boy undergoes bypass surgery at Fortis Escort Heart Institute savita thakur thakur30 March 2016 1:43 PM ISTNew Delhi: Fortis Escorts Heart Institute (FEHI) recently conducted a successful bypass on the youngest Indian ever with a ten year old boy undergoing...
